Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2021, 2(1); doi: 10.25236/AJMHS.2021.020114.

Reduction-Sensitive Polymeric Micelles for Intracellular Doxorubicin Delivery

Author(s)

Xiaoyi Zhang1, Yue Zhuang2, Lecun Yang3, Yongkang Liu4

Corresponding Author:
Xiaoyi Zhang
Affiliation(s)

1Department of Pharmacy, Shihezi University, Shihezi City, Xinjiang Province, China

2College of Overseas Education, Nanjing Tech University, Nanjing City, Jiangsu Province, China 

3School of Life Science and Technology, China Pharmaceutical University, Nanjing City, Jiangsu Province, China

4Chengdu Shude High School, Chengdu City, Sichuan Province, China

These authors contributed equally to this work

Abstract

The hazard of cancer is continuously increasing with age, Doxorubicin (DOX) encapsulated by liposomes as an effective formulation is widely used to treat malignancies. To avoid the cardiotoxicity of DOX and increase the half-life and targeting of liposomal drugs, redox-sensitive nanoparticle that improve the delivery of therapeutics to target tissue have become an extensive choice of medical treatment. In this work, we synthesised a kind of redox-sensitive product, PEG-redox-DOX micelles which were made of PEG-SS-COOH coupled with DOX by a reduction-sensitive disulfide bond. This micellar system has a mean diameter of 60nm with acceptable distribution (PDI=0.81) and remained unchanged in phate buffered saline (PBS, pH=7.4) for 24 hours. However, the disulfide bond between DOX and hydrophilic PEG broke readily in the presence of 10 mM DTT imitating intracellular condition. The micelle released more than 75% DOX within 48h at 10 mM DTT, whereas only 12% DOX were released from prodrug at 0 mM DTT. These results suggest that PEG-redox-DOX has expectable efficiency of drug-loading and release. Nowadays, redox-sensitive micelles are more and more taken into considered, demonstrating its developmental potential in cancer therapy categories by providing a new search direction. 

Keywords

Reduction-Sensitive Polymeric,Doxorubicin,Micelles

Cite This Paper

Xiaoyi Zhang, Yue Zhuang, Lecun Yang, Yongkang Liu. Reduction-Sensitive Polymeric Micelles for Intracellular Doxorubicin Delivery. Academic Journal of Medicine & Health Sciences (2021) Vol. 2, Issue 1: 80-87. https://doi.org/10.25236/AJMHS.2021.020114.

References

[1] Rajeshuni Nitya., Johnston Emily E., Saynina Olga., Sanders Lee M., Chamberlain Lisa J.(2017). Disparities in location of death of adolescents and young adults with cancer: A longitudinal, population study in California. Cancer, 123(21), 4178-4184. 

[2] Yang Min., Ding Houqiang., Zhu Yixin., Ge Yanxiu., Li Lingbing.(2019). Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugs. Colloids Surf B Biointerfaces, 175(undefined), 126-135. 

[3] Perez-Fidalgo J A., Cortés A., Guerra E., García Y., Iglesias M., Bohn Sarmiento U., Calvo García E., Manso Sánchez L., Santaballa A., Oaknin A., Redondo A., Rubio M J., González-Martín A.(2021). Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study). ESMO Open, 6(4), 100212. 

[4] Yin Wang., Xiang Dongxi., Wang Tao., Zhang Yumei., Pham Cuong V., Zhou Shufeng., Jiang Guoqin., Hou Yingchun., Zhu Yimin., Han Yinglu., Qiao Liang., Tran Phuong H-L., Duan Wei.(2021). The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells. Sci Rep, 11(1), 10791. doi:10.1038/s41598-021-89931-9

[5] Gao Yi., Zhu Yue., Xu Xiaopeng., Wang Fangjun., Shen Weidong., Leng Xia., Zhao Jiyi., Liu Bingtuan., Wang Yangyun., Liu Pengfei.(2021). Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma. Front Cell Dev Biol, 9(undefined), 688070. 

[6] Xintao Shuai.(2014).Stimuli-sensitive polymeric nanocarriers for drug/siRNA delivery.(eds.) Abstracts of the sixth International Symposium on Polymer Chemistry (pp.213).

[7] Shen Youqing., Jin Erlei., Zhang Bo., Murphy Caitlin J., Sui Meihua., Zhao Jian., Wang Jinqiang., Tang Jianbin., Fan Maohong., Van Kirk Edward., Murdoch William J.(2010). Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc, 132(12), 4259-65. 

[8] Harishkumar Rajendran., Christopher Johnsamuel Godwin., Ravindran Rajan., Selvaraj Chinnadurai Immanuel.(2021). Nuciferine Attenuates Doxorubicin-Induced Cardiotoxicity: An In Vitro and In Vivo Study. Cardiovasc Toxicol, undefined(undefined), undefined. 

[9] Lien Chia-Ying., Lu Chen-Wen., Lin Yi-Hsuan., Wu Wan-Jhen., Hsu Chih-Hsiang., Chuang Tai-Yuan., Lin Kuei-Fu., Chuang Wu-Chang., Lee Ming-Chung., Wu Chung-Hsin.(2021). Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models. Evid Based Complement Alternat Med, 2021(undefined), 5548968. 

[10] Dutta Bijaideep., Barick K C., Hassan P A.(2021). Recent advances in active targeting of nanomaterials for anticancer drug delivery. Adv Colloid Interface Sci, 296(undefined), 102509. 

[11] Zhu Lusha., Lin Mei.(2020). The Synthesis of Nano-Doxorubicin and its Anticancer Effect. Anticancer Agents Med Chem, undefined(undefined), undefined. 

[12] Huang Da., Zhuang Yaping., Shen Hong., Yang Fei., Wang Xing., Wu Decheng.(2018). Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery. Mater Sci Eng C Mater Biol Appl, 82(undefined), 60-68. 

[13] Chen Jun., Qiu Xiaozhong., Ouyang Jun., Kong Jiming., Zhong Wen., Xing Malcolm M Q.(2011). pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery. Biomacromolecules, 12(10), 3601-11. 

[14] Park June Yong., Shin Yuseon., Won Woong Roeck., Lim Chaemin., Kim Jae Chang., Kang Kioh., Husni Patihul., Lee Eun Seong., Youn Yu Seok., Oh Kyung Taek.(2021). Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells. Int J Nanomedicine, 16(undefined), 5437-5449. 

[15] Tan Cuiying., Zheng Jingqi., Feng Yue., Liu Mingxian.(2021). Cell Membrane-Coated Halloysite Nanotubes for Target-Specific Nanocarrier for Cancer Phototherapy. Molecules, 26(15), undefined. 

[16] Li Dawei., Bu Yazhong., Zhang Lining., Wang Xing., Yang Yanyu., Zhuang Yaping., Yang Fei., Shen Hong., Wu Decheng.(2016). Facile Construction of pH- and Redox-Responsive Micelles from a Biodegradable Poly(β-hydroxyl amine) for Drug Delivery. Biomacromolecules, 17(1), 291-300. 

[17] Liu Jinyao., Pang Yan., Huang Wei., Huang Xiaohua., Meng Lili., Zhu Xinyuan., Zhou Yongfeng., Yan Deyue.(2011). Bioreducible micelles self-assembled from amphiphilic hyperbranched multiarm copolymer for glutathione-mediated intracellular drug delivery. Biomacromolecules, 12(5), 1567-77. 

[18] Yin Tingjie., Wu Qu., Wang Lei., Yin Lifang., Zhou Jianping., Huo Meirong.(2015). Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Mol Pharm, 12(8), 3020-31.

[19] Xia Haoran., Liang Yan., Chen Keqi., Guo Chunhua., Wang Mengdi., Cao Jie., Han Shangcong., Ma Qingming., Sun Yong., He Bin.(2021). Reduction-sensitive polymeric micelles as amplifying oxidative stress vehicles for enhanced antitumor therapy. Colloids Surf B Biointerfaces, 203(undefined), 111733. 

[20] Yi Xiaoqing., Zhang Quan., Dong Hui., Zhao Dan., Xu Jia-qi., Zhuo Renxi., Li Feng.(2015). One-pot synthesis of crosslinked amphiphilic polycarbonates as stable but reduction-sensitive carriers for doxorubicin delivery. Nanotechnology, 26(39), 395602. 

[21] Bobde Yamini., Paul Milan., Patel Tarun., Biswas Swati., Ghosh Balaram.(2021). Polymeric micelles of a copolymer composed of all-trans retinoic acid, methoxy-poly(ethylene glycol), and b-poly(N-(2 hydroxypropyl) methacrylamide) as a doxorubicin-delivery platform and for combination chemotherapy in breast cancer. Int J Pharm, 606(undefined), 120866. 

[22] Chen Yi-Chun., Chang Chang-Jung., Hsiue Ging-Ho., Chiang Yi-Ting.(2021). Doxorubicin-Loaded Mixed Micelles Using Degradable Graft and Diblock Copolymers to Enhance Anticancer Sensitivity. Cancers (Basel), 13(15), undefined. 

[23] (a) Schmalenberg, K. E.; Frauchiger, L.; Nikkhouy-Albers, L.; Uhrich, K. E. Biomacromolecules 2001, 2, 851−855. (b) Liu, J. Y.; Pang, Y.; Huang, W.; Huang, X. H.; Meng, L. L.; Zhu, X. Y.; Zhou, Y. F.; Yan, D. Y. Biomacromolecules 2011, 12, 1567−1577.

[24] Jun Chen,Xiaozhong Qiu,Jun Ouyang,Jiming Kong,Wen Zhong,O and Malcolm M. Q. Xing[1]pH and Reduction Dual-Sensitive Copolymeric Micelles for Intracellular Doxorubicin Delivery[J]. Biomacromolecules, 2011.